Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2004-2-4
pubmed:abstractText
This study was designed to assess the feasibility and safety of enoxaparin in combination with glycoprotein (GP) IIb/IIIa inhibitors during percutaneous coronary intervention (PCI) as part of an early invasive strategy in patients presenting with acute coronary syndromes (ACS).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1042-3931
pubmed:author
pubmed:issnType
Print
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
46-51
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:14760188-Acute Disease, pubmed-meshheading:14760188-Angioplasty, Balloon, Coronary, pubmed-meshheading:14760188-Anticoagulants, pubmed-meshheading:14760188-Coronary Disease, pubmed-meshheading:14760188-Drug Therapy, Combination, pubmed-meshheading:14760188-Enoxaparin, pubmed-meshheading:14760188-Factor Xa, pubmed-meshheading:14760188-Female, pubmed-meshheading:14760188-Humans, pubmed-meshheading:14760188-Male, pubmed-meshheading:14760188-Middle Aged, pubmed-meshheading:14760188-Ohio, pubmed-meshheading:14760188-Pilot Projects, pubmed-meshheading:14760188-Platelet Aggregation Inhibitors, pubmed-meshheading:14760188-Platelet Glycoprotein GPIIb-IIIa Complex, pubmed-meshheading:14760188-Prospective Studies, pubmed-meshheading:14760188-Syndrome, pubmed-meshheading:14760188-Time Factors, pubmed-meshheading:14760188-Treatment Outcome
pubmed:year
2004
pubmed:articleTitle
The combination of enoxaparin, glycoprotein IIb/IIIa inhibitors and an early invasive approach among acute coronary syndrome patients.
pubmed:affiliation
Cleveland Clinic Foundation, Department of Cardiovascular Medicine, Desk F25, 9500 Euclid Avenue, Cleveland, OH 44195, USA. bhattd@ccf.org
pubmed:publicationType
Journal Article, Clinical Trial, Controlled Clinical Trial, Research Support, Non-U.S. Gov't